EC Approves Teva's Generic Version Of Neupogen
By Jesse Greenspan · September 16, 2008, 12:00 AM EDT
In a still relatively rare approval of a biosimilar drug, Israeli generic-drug maker Teva Pharmaceutical Industries Ltd. announced Tuesday that the European Commission had approved a copycat version of Amgen Inc.'s...
To view the full article, register now.